NONMEM Users Network Archive

Hosted by Cognigen

(no subject)

From: Yvonne Andersson <yvonne.andersson>
Date: Wed, 20 Jan 2010 08:47:02 +0100




Dear Colleague,


Please find information about two upcoming courses arranged by the =
Swedish Academy of Pharmaceutical Sciences.



Introduction to Quantitative Pharmacology and PK/PD for Drug Discovery & =
Development Scientists, Munich, Germany, September 2-3, 2010


This course aims to give the delegates confidence and encouragement to =
have a go at PKPD and to build relationships between bioscience, DMPK, =
medicinal chemistry and related scientific disciplines. The programme is =
comprised of lectures and afternoon group exercises.


Course objectives
* To raise awareness amongst bioscience, medicinal chemistry and =
clinical scientists of what kinetic-dynamic (PKPD) methods can offer

* To raise awareness of the individual steps that makes up the =
dose-plasma-distribution-binding-turnover- response process

* To raise awareness of experimental design. What investment has to be =
done early and late in discovery?

* To build a case for the assessment of the first time in man dose

* To provide theory and methods of in vivo PKPD data

Who should attend?
Bioscience, safety, medicinal chemistry and clinical scientists, =
statisticians, pharmacokineticists, pharmacologists etc.

* PK from a PD point of view

* PK half-life vs. half-life of response

* The apparent disconnection between PK and PD

* Emax-models and their difficulties if maximum response is lacking

* Effect compartment models in (distribution-rate limited) responses

* Turnover models in (turnover-rate limited) responses

* Receptor on/off binding models in (binding-rate limited) responses

* Scaling pharmacodynamics and PK properties to man

* Practical experimental design of PD studies

* PKPD assessment at milestone decisions


For further information, please visit our website: =







The 17th Intermediate Workshop on PK/PD Data Analysis: A Hands-on Course =
Using WinNonlin, Rome, Italy, September 26-30, 2010



Course outline

Morning sessions consist of lectures dealing with choice of weights, =
goodness-of-fit, interpretation of computer output, experimental design =
and discrimination between rival models. Afternoon sessions are devoted =
to applying the methods discussed in the lectures to actual data, using =
WinNonlin. One afternoon session will be given as an introduction for =
participants with no, or very little, experience with WinNonlin. The =
participants work on their own laptops during the hands-on sessions.



Who should attend?

This workshop is intended for individuals engaged in the pharmaceutical =
industry, regulatory agencies, contract research companies and =
universities and for others who want to learn the aspects of model =
fitting. Previous participants have been toxicologists, kineticists, =
bioanalytical chemists, pharmacologists, clinical pharmacologists, =
anaesthesiologists, clinical research assistants and scientists from =
academia and regulatory agencies. Participants should have a background =
in pharmacokinetics but those with limited experience would also =
benefit. The number of participants is limited.



*Introduction and overview

*Assessment of goodness of fit

*Pharmacodynamic issues

*Design of experiments

*Comparison of models


For further information, please visit:



With kind regards,


Annica Flodin, Projektadministratör/Project Administrator


Box 1136, 111 81 Stockholm, Sweden

Besöksadress: Wallingatan 26A

Tel. 08-723 50 40; Fax 08-20 55 11

E-mail: annica.flodin

Hemsida: <>








(image/jpeg attachment: image003.jpg)

Received on Wed Jan 20 2010 - 02:47:02 EST

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: